摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1H-噻吩并[2,3-d]咪唑,1-乙烯基-(9CI) | 193066-58-9

中文名称
1H-噻吩并[2,3-d]咪唑,1-乙烯基-(9CI)
中文别名
1-乙烯基-1H-噻吩并[2,3-d]咪唑
英文名称
1-Vinyl-1H-thieno[2,3-d]imidazole
英文别名
1H-Thieno[2,3-d]imidazole,1-ethenyl-(9CI);1-ethenylthieno[2,3-d]imidazole
1H-噻吩并[2,3-d]咪唑,1-乙烯基-(9CI)化学式
CAS
193066-58-9
化学式
C7H6N2S
mdl
——
分子量
150.204
InChiKey
OANLVFSWCBREHT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    46.1
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1H-噻吩并[2,3-d]咪唑,1-乙烯基-(9CI)potassium permanganate 作用下, 以 丙酮 为溶剂, 以99%的产率得到1H-thieno[2,3-d]imidazole
    参考文献:
    名称:
    乙烯基作为唑N-原子的有效保护基的用途:多官能咪唑和噻吩并[2,3- d ]⇌[3,2- d ]咪唑的合成
    摘要:
    由2,4,5-三溴咪唑和1,2-二溴乙烷制得2,4,5-三溴-1-乙烯基咪唑,并通过Br→MgBr等交换反应以2→5→4的顺序选择性取代其Br原子反应。用臭氧或高锰酸钾可有效地从所得的多官能化咪唑中除去乙烯基。此方法的扩展允许首次合成噻吩并[2,3- d ]⇌[3,2- d ]-咪唑。
    DOI:
    10.1016/s0040-4039(97)00957-x
  • 作为产物:
    参考文献:
    名称:
    乙烯基作为唑N-原子的有效保护基的用途:多官能咪唑和噻吩并[2,3- d ]⇌[3,2- d ]咪唑的合成
    摘要:
    由2,4,5-三溴咪唑和1,2-二溴乙烷制得2,4,5-三溴-1-乙烯基咪唑,并通过Br→MgBr等交换反应以2→5→4的顺序选择性取代其Br原子反应。用臭氧或高锰酸钾可有效地从所得的多官能化咪唑中除去乙烯基。此方法的扩展允许首次合成噻吩并[2,3- d ]⇌[3,2- d ]-咪唑。
    DOI:
    10.1016/s0040-4039(97)00957-x
点击查看最新优质反应信息

文献信息

  • TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS
    申请人:FINE POLYMERS CORPORATION
    公开号:US20150279654A1
    公开(公告)日:2015-10-01
    The invention provides an aqueous solution capable of selectively protecting a nitrogen-containing silicon compound from corrosion by a treating solution for etching, cleaning or the like, etching oxygen-containing, carbon-containing silicon in particular, and making a large etch rate difference between a nitrogen-containing silicon compound and an oxygen-containing silicon compound, and a process for producing electronic parts as well. The invention is embodied by a treating solution for electronic parts that is an aqueous solution containing one or two or more of anionic surface active agents represented by the following formulae (1), (2) and (3), and a process for producing an electronic part. wherein R 1 , R 2 , and R 3 stands for hydrogen or an alkyl or alkylene group having 1 to 4 carbon atoms, and X 1 stands for a functional group capable of becoming an anionic ion. wherein R 4 stands for hydrogen or an alkyl or alkylene group having 1 to 4 carbon atoms, X 2 stands for a functional group capable of becoming an anionic ion, and n stands for a natural number of greater than 2. wherein R 5 stands for hydrogen or an alkyl or alkylene group having 1 to 4 carbon atoms, and X 3 , and X 4 stands for a functional group capable of becoming an anionic ion.
  • US9812315B2
    申请人:——
    公开号:US9812315B2
    公开(公告)日:2017-11-07
查看更多

同类化合物

沙维拉唑 4H-吡咯并[1,2-a]噻吩并[3,2-D]咪唑 3H-噻吩并[2,3-d]咪唑-5-羧酸 3-甲基-1H-噻吩并[2,3-d]咪唑-2(3h)-酮 2-(氯甲基)-1H-噻吩并[3,4-d]咪唑 1H-噻吩并[3,2-D]咪唑-2(3H)-酮 1H-噻吩并[2,3-d]咪唑,1-乙烯基-(9CI) 1H-噻吩并(3,4-d)咪唑,2-(((5-甲基-2-吡啶基)甲基)亚硫酰基)- 1-甲基-1H-噻吩并[2,3-D]咪唑基-2(3H)-酮 1-乙烯基-1H-噻吩并[2,3-d]咪唑-5-羧酸 1,3-二氢噻吩并[3,4-d]咪唑-2-硫酮 2-(3-Chloro-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(1-isopropyl-pyrrolo[3,2-b]pyridin-5-yl)-4-methyl-1,3-thiazole-5-carboxylic acid isopropyl ester 2-(3-cyano-1-isopropyl-pyrrolo[3,2-b]pyridin-5-yl)-4-methyl-1,3-thiazole-5-carboxylic acid isopropyl ester 2-(5-Methoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(4-ethoxy-benzyl)-1(3)H-thieno[2,3-d]imidazole 3,4,8-triamino-1H-pyrazolo<3,4-d>thieno<2,3-b>pyridin-7-carbonsaeure-ethylester 1-[2-(5-Methyl-pyridin-2-ylmethanesulfinyl)-3H-thieno[3,4-d]imidazol-6-yl]-ethanone 2-Oxo-2,3-dihydro-4-methyl-1H-thieno<3,4-d>imidazol 2-[4-(2,2,2-trifluoroethyloxy)-2-picolylsulfinyl]-4,6-dimethyl-1H-thieno[3,4-d]imidazole 1,2-dimethyl-N-{2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethyl}-1H-thieno[3, 4-d]imidazole-4-carboxamide 2-[4-(2,2,3,3,3-pentafluoropropyloxy)-2-picolylsulfinyl]-4,6-dimethyl-1H-thieno[3,4-d]imidazole 2-(3-Fluoro-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-[(3-methoxypyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole 2-(5-Methyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrobromide 2-(3,5-Dimethyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride ethyl 6-ethyl-1-methyl-3-(1-methylethoxy)-5-[(thiophen-2-ylcarbonyl)amino]-1H-pyrrolo[2,3-b]pyridine-2-carboxylate 1H-thieno[3,4-d]imidazol-2(3H)-one 2-(4-piperidino-3-chloro-2-picolylmercapto)-1H-thieno[3,4-d]imidazole 4,6-Dimethyl-2-(pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride 2-(3-Methyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride ethyl 2-benzylthio-1-methoxymethyl-1H-thieno<2,3-d>imidazole-5-carboxylate 2-(6-Methyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride 2-(4-Methoxy-pyridin-2-ylmethylsulfanyl)-4,6-dimethyl-1H-thieno[3,4-d]imidazole; hydrochloride 2-(4-Ethoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride 2-[(3-methylpyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole Methyl 2-oxo-1,3-dihydrothieno[3,4-d]imidazole-4-carboxylate 2-oxo-2,3-dihydro-4-(δ-N-methylcarbamidobutyl)-1H-thieno<3,4-d>imidazole methyl 2-hexylthio-4-methylthieno[3,4-d]imidazole-6-carboxylate methyl 2-butylthio-4-methylthieno[3,4-d]imidazole-6-carboxylate dimethyl 4-methyl-4H-pyrrolo[3,2-d][1,3]thiazole-2,5-dicarboxylate 2-[4-(2,2,3,3,4,4,4-heptafluorobutyloxy)-2-picolylsulfinyl]-4,6-dimethyl-1H-thieno[3,4-d]imidazole 2-(3,5-Dimethyl-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 4,6-Dimethyl-2-(pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-Ethoxy-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-Methoxy-pyridin-2-ylmethanesulfinyl)-4,6-dimethyl-1H-thieno[3,4-d]imidazole 2-bromo-4H-pyrrolo[3,2-d]thiazole-5-carboxylic acid amide 4-phenyl-2-(pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-bromo-4H-pyrrolo[3,2-d]thiazole-5-carboxylic acid 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-4-(4-methoxyphenyl)-1H-thieno[3,4-d]imidazole